Advanced Therapy Medicinal Products and Exemptions to the Regulation 1394/2007: How Confident Can We be? An Exploratory Analysis.
about
Developing Induced Pluripotent Stem Cell-Based Therapy for the MassesBusiness oriented EU human cell and tissue product legislation will adversely impact Member States' health care systems.Rapid Chondrocyte Isolation for Tissue Engineering Applications: The Effect of Enzyme Concentration and Temporal Exposure on the Matrix Forming Capacity of Nasal Derived ChondrocytesDevelopment of a cell-based medicinal product: regulatory structures in the European Union.Determinants of clinician adoption of regenerative therapies in the UK and Canada: an ophthalmology perspective.Challenges in Advanced Therapy Medicinal Product Development: A Survey among Companies in Europe
P2860
Advanced Therapy Medicinal Products and Exemptions to the Regulation 1394/2007: How Confident Can We be? An Exploratory Analysis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Advanced Therapy Medicinal Pro ...... e be? An Exploratory Analysis.
@en
type
label
Advanced Therapy Medicinal Pro ...... e be? An Exploratory Analysis.
@en
prefLabel
Advanced Therapy Medicinal Pro ...... e be? An Exploratory Analysis.
@en
P2860
P356
P1476
Advanced Therapy Medicinal Pro ...... e be? An Exploratory Analysis.
@en
P2093
Philippe Van Wilder
P2860
P356
10.3389/FPHAR.2012.00012
P577
2012-02-14T00:00:00Z